SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000899140-15-000172
Filing Date
2015-02-05
Accepted
2015-02-05 11:52:12
Documents
2
Group Members
ALEXANDER J. DENNERSARISSA CAPITAL DOMESTIC FUND LPSARISSA CAPITAL OFFSHORE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D s13da.htm SC 13D 141981
2 JOINT FILING AGREEMENT s13db.htm EX-1 10789
  Complete submission text file 0000899140-15-000172.txt   154537
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85739 | Film No.: 15578809
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D